[1]
Secrest, MSc, M.H., Phillips, MPH, S., Cepeda, MD, PhD, M.S., Kern, MS, PhD, D.M., Esposito, MPH, PhD, D.B. and Wedin, PharmD, G.P. 2023. Impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategy on prescribing practices. Journal of Opioid Management. 19, 2 (Mar. 2023), 99–110,A1. DOI:https://doi.org/10.5055/jom.2023.0764.